Healthcare

Embecta, a specialized diabetes care company, is currently presenting investors with a puzzling dichotomy. Despite posting solid quarterly figures and...

Huron Consulting Group has delivered a powerful demonstration of growth in its second quarter 2025 results, prompting a significant upward...

Deciphera Pharmaceuticals has achieved a pivotal regulatory victory with the European Commission granting marketing authorization for its drug ROMVIMZA™. The...

The medical technology firm CONMED has appointed a new director to its board, bringing in seasoned industry executive Kim Kelderman,...

Intuitive Surgical's latest financial performance presents investors with a complex narrative of impressive operational achievements tempered by concerning financial headwinds....

The American healthcare giant UnitedHealth finds itself navigating increasingly turbulent waters. A disappointing 2025 profit forecast, the collapse of a...

The biotechnology firm Ardelyx approaches a definitive moment in its corporate history. A court ruling scheduled for September 25th will...

French biotechnology firm Valneva has encountered a severe regulatory obstacle following the US Food and Drug Administration's (FDA) immediate suspension...

Tenet Healthcare's stock performance continues to impress investors, propelled by exceptional quarterly results and overwhelmingly positive analyst sentiment. However, beneath...

The American healthcare behemoth UnitedHealth Group continues to struggle with a severe financial downturn, showing little sign of a near-term...